< Back to latest news & events

News

UK Address for Service for Intellectual Property Rights from 1 January 2021

November 2020

The UK Government response to call for views on Address for Service (AfS) has been published. This confirms that new UK trade mark, design and patent applications and oppositions from 1 January 2021 will need an address in the UK, Gibraltar or the Channel Islands (subject to legislative implementation).

This means the UKIPO will no longer accept addresses in the EEA. A UK address for service will not be required for the renewal of existing registered or granted rights. The rules will include transitional provisions for ongoing cases. EU Trade Mark and Registered Community Design rights that will be re-created on the UK register will not need a UK address for service in the three years following the end of the Brexit transition period.

A full UKIPO business guide to the changes can be found here.

CIPA President Richard Mair said:

“This is an excellent development. It corrects a gross inequality which our Members have had to suffer over the last few years. The UK has allowed addresses for service anywhere in the EEA, while countries such as Germany have insisted on retaining a monopoly of representation by locally qualified practitioners. So we shall at last have a level playing field.”

CITMA President Richard Goddard said:

“This will be a positive change and will help protect the UK’s world-leading intellectual property environment, those who work within it and the businesses who rely on the expertise of UK IP legal professionals. It is in the interests of IP owners with UK rights to have a qualified professional who is familiar with UK law and practice advising them.”

HGF will continue to represent clients for all matters before the UKIPO in respect of IP Rights. If you would like further advice on this matter, or to appoint HGF as your agent with a UK Address for Service, please speak to your usual attorney or contact us.

Latest updates

Event - 11th November 2025

OIS Investor Forum - Jeffries

HGF is proud to be sponsoring the OIS Investor Forum on 18th November. One of the premier gatherings for leaders, innovators, and investors across the healthcare industry. The forum covers …

Event details

From Stripes to Supermarkets: The Court of Appeal Reaffirms the Need for Precision in Trade Mark Law

On 23 October 2025, Lord Justice Arnold delivered two landmark Court of Appeal decisions addressing trade mark registrability: Thom Browne Inc & Anor v adidas AG [2025] EWCA Civ 1340 …

Read article

Protecting Digital Health innovation in the AI revolution

As artificial intelligence (AI) continues to transform healthcare, from diagnostic imaging and drug discovery to wearable devices and clinical decision support, questions around how to protect these advancements have become …

Read article

Doubling Up on Added Matter at the UPC

Following the UPC Court of Appeal (CoA) decision in Abbott v Sibio (APL_39664/2024, 14 February 2025) we now have a second CoA decision on added matter in expert Klein v …

Read article
Event - 4th November 2025

HGF are Silver Sponsors of LSPN Europe 2025

HGF is proud to be a Silver Sponsor of LSPN Europe 2025, a leading forum dedicated to helping life sciences innovators protect and leverage their intellectual property across the entire …

Event details
Event - 30th - 31st October 2025

RAPS European Digital Technologies and Software conference

HGF is proud to be attending the RAPS European Digital Technologies and Software conference in The Netherlands on 30th-31st October. HGF Partner and Patent Attorney Janine Swarbrick and Patent Director …

Event details

Protect It Before You Promote It: IP Advice for MedTech Innovators

Developed a new medical product? Check. Got tickets to an exciting MedTech conference to show off your new product? Check. Intellectual property? Pardon? In the excitement of bringing a new …

Read article

Agritech Thymes: The Bite of Implied Consent: Lessons from the Pink Lady Case

Can the supply of a plant variety without clear and defined restrictions on its use be an implicit consent to commercialise it? This case centres on the evidence required to …

Read article